During these uncertain times, we are more conscious than ever of our need to support and nurture our pharmacology community. The Society is here for you to facilitate connection with each other, and…
A new review, published in the British Journal of Pharmacology, from a team of researchers representing the International Union of Basic and Clinical Pharmacology (IUPHAR), identifies…
The government has published its COVID-19 recovery strategy, ‘Our plan to rebuild’, setting out a series of phases as part of this plan. Phase three recognises the critical importance of accelerating…
When we think of pharmacology as a discipline, it’s easy to imagine research careers in a university or industry setting. At public engagement events, it’s not uncommon for pharmacology to be…
Are all patients with inflammatory bowel disease (IBD) are psychologically strong enough to endure the sudden onset of a chronic disease? Personally, my answer is no. I was not ready to face a…
Every year, there are approximately 1000 new spinal cord injury (SCI) cases. Currently, more than 40,000 people in the UK live with this debilitating condition, which has no cure – a huge financial…
Today, the Society has joined partner organisations in the UK research and innovation sector in calling for competitively costed visas for international scientists. The call comes ahead of the…
The ambitions to conduct more clinical research in the UK could be achieved by strategic investment in the clinical research workforce, according to new joint FORUM report, Shaping the future…
Animal models used in the global effort to find a treatment for COVID-19 must be valid – and they must be used and reported consistently. Society President-Elect Professor Clive Page and colleagues,…
Recently, the Society’s Education and Training Committee met to talk about how delivering pharmacology education has changed since the outbreak of the novel coronavirus disease, COVID-19. We shared…
